Systemic inflammation switches the inflammatory cytokine profile in CNS Wallerian degeneration

Neurobiology of Disease

Volumn 30, Issue 1, 2008, Pages 19-29

  Palin, Karine ^a   Cunningham, Colm ^a   Forse, Penny ^a   Perry, V Hugh ^a   Platt, Nick ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Axon; Lipopolysaccharide; Microglia; Neurodegeneration

Indexed keywords

ENDOTOXIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DEGENERATIVE DISEASE; FEMALE; IMMUNOREACTIVITY; INFLAMMATION; MACROPHAGE; MICROGLIA; MOUSE; NERVE FIBER DEGENERATION; NEUROFILAMENT; NEUROPATHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; OPTIC NERVE; PERIKARYON; PHAGOCYTOSIS; PRION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; C-REACTIVE PROTEIN; CENTRAL NERVOUS SYSTEM; CYCLOOXYGENASE 2; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; MICE; MICE, INBRED C57BL; MICROGLIA; NITRIC OXIDE SYNTHASE TYPE II; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYSACCHARIDES; SERUM AMYLOID P-COMPONENT; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA; WALLERIAN DEGENERATION;

EID: 40849095836     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2007.11.012     Document Type: Article

References (49)

1. Allan S.M., Tyrrell P.J., and Rothwell N.J. Interleukin-1 and neuronal injury. Nat. Rev. Immunol. 5 (2005) 629-640
2. Bendszus M., and Stoll G. Caught in the act: in vivo mapping of macrophage infiltration in nerve injury by magnetic resonance imaging. J. Neurosci. 23 (2003) 10892-10896
3. Bignami A., Dahl D., Nguyen B.T., and Crosby C.J. The fate of axonal debris in Wallerian degeneration of rat optic and sciatic nerves. Electron microscopy and immunofluorescence studies with neurofilament antisera. J. Neuropathol. Exp. Neurol. 40 (1981) 537-550
4. Block M.L., and Hong J.S. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog. Neurobiol. 76 (2005) 77-98
5. Boche D., Cunningham C., Docagne F., Scott H., and Perry V.H. TGFbeta1 regulates the inflammatory response during chronic neurodegeneration. Neurobiol. Dis 22 3 (2006) 638-650
6. Bottazzi B., Garlanda C., Salvatori G., Jeannin P., Manfredi A., and Mantovani A. Pentraxins as a key component of innate immunity. Curr. Opin. Immunol. 18 (2006) 10-15
7. Boven L.A., Van Meurs M., Van Zwam M., Wierenga-Wolf A., Hintzen R.Q., Boot R.G., Aerts J.M., Amor S., Nieuwenhuis E.E., and Laman J.D. Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis. Brain 129 (2006) 517-526
8. Coleman M.P., Conforti L., Buckmaster E.A., Tarlton A., Ewing R.M., Brown M.C., Lyon M.F., and Perry V.H. An 85-kb tandem triplication in the slow Wallerian degeneration (Wlds) mouse. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 9985-9990
9. Coleman M.P., and Perry V.H. Axon pathology in neurological disease: a neglected therapeutic target. Trends Neurosci. 25 (2002) 532-537
10. Combrinck M.I., Perry V.H., and Cunningham C. Peripheral infection evokes exaggerated sickness behaviour in pre-clinical murine prion disease. Neuroscience 112 (2002) 7-11
11. Cunningham C., Boche D., and Perry V.H. Transforming growth factor beta1, the dominant cytokine in murine prion disease: influence on inflammatory cytokine synthesis and alteration of vascular extracellular matrix. Neuropathol. Appl. Neurobiol. 28 (2002) 107-119
12. Cunningham C., Deacon R., Wells H., Boche D., Waters S., Diniz C.P., Scott H., Rawlins J.N., and Perry V.H. Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease. Eur. J. Neurosci. 17 (2003) 2147-2155
13. Cunningham C., Wilcockson D.C., Boche D., and Perry V.H. Comparison of inflammatory and acute-phase responses in the brain and peripheral organs of the ME7 model of prion disease. J. Virol. 79 (2005) 5174-5184
14. Cunningham C., Wilcockson D.C., Campion S., Lunnon K., and Perry V.H. Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J. Neurosci. 25 (2005) 9275-9284
15. Drager U.C., and Hubel D.H. Topography of visual and somatosensory projections to mouse superior colliculus. J. Neurophysiol. 39 (1976) 91-101
16. Fadok V.A., Bratton D.L., Konowal A., Freed P.W., Westcott J.Y., and Henson P.M. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 101 (1998) 890-898
17. Fitzgerald M.L., Moore K.J., Freeman M.W., and Reed G.L. Lipopolysaccharide induces scavenger receptor A expression in mouse macrophages: a divergent response relative to human THP-1 monocyte/macrophages. J. Immunol. 164 (2000) 2692-2700
18. Friedlander R.M. Apoptosis and caspases in neurodegenerative diseases. N. Engl. J. Med. 348 (2003) 1365-1375
19. George R., and Griffin J.W. Delayed macrophage responses and myelin clearance during Wallerian degeneration in the central nervous system: the dorsal radiculotomy model. Exp. Neurol. 129 (1994) 225-236
20. Graumann U., Reynolds R., Steck A.J., and Schaeren-Wiemers N. Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective mechanisms against hypoxic insult. Brain Pathol. 13 (2003) 554-573
21. Grygielko E.T., Martin W.M., Tweed C., Thornton P., Harling J., Brooks D.P., and Laping N.J. Inhibition of gene markers of fibrosis with a novel inhibitor of transforming growth factor-beta type I receptor kinase in puromycin-induced nephritis. J. Pharmacol. Exp. Ther. 313 (2005) 943-951
22. Guo B., Slevin M., Li C., Parameshwar S., Liu D., Kumar P., Bernabeu C., and Kumar S. CD105 inhibits transforming growth factor-beta-Smad3 signalling. Anticancer Res. 24 (2004) 1337-1345
23. Holness C.L., da Silva R.P., Fawcett J., Gordon S., and Simmons D.L. Macrosialin, a mouse macrophage-restricted glycoprotein, is a member of the lamp/lgp family. J. Biol. Chem. 268 (1993) 9661-9666
24. Lawson L.J., Frost L., Risbridger J., Fearn S., and Perry V.H. Quantification of the mononuclear phagocyte response to Wallerian degeneration of the optic nerve. J. Neurocytol. 23 (1994) 729-744
25. Levi G., Minghetti L., and Aloisi F. Regulation of prostanoid synthesis in microglial cells and effects of prostaglandin E2 on microglial functions. Biochimie 80 (1998) 899-904
26. Liefner M., Siebert H., Sachse T., Michel U., Kollias G., and Bruck W. The role of TNF-alpha during Wallerian degeneration. J. Neuroimmunol. 108 (2000) 147-152
27. Logan A., Frautschy S.A., Gonzalez A.M., Sporn M.B., and Baird A. Enhanced expression of transforming growth factor beta 1 in the rat brain after a localized cerebral injury. Brain Res. 587 (1992) 216-225
28. Luo L., and O'Leary D.D. Axon retraction and degeneration in development and disease. Annu. Rev. Neurosci. 28 (2005) 127-156
29. MacMicking J., Xie Q.W., and Nathan C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15 (1997) 323-350
30. Mattson M.P. Apoptotic and anti-apoptotic synaptic signaling mechanisms. Brain Pathol. 10 (2000) 300-312
31. McDonald P.P., Fadok V.A., Bratton D., and Henson P.M. Transcriptional and translational regulation of inflammatory mediator production by endogenous TGF-beta in macrophages that have ingested apoptotic cells. J. Immunol. 163 (1999) 6164-6172
32. Minghetti L., and Levi G. Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide. Prog. Neurobiol. 54 (1998) 99-125
33. Perry V.H. The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease. Brain Behav. Immun. 18 (2004) 407-413
34. Perry V.H., Cunningham C., and Boche D. Atypical inflammation in the central nervous system in prion disease. Curr. Opin. Neurol. 15 (2002) 349-354
35. Perry V.H., Cunningham C., and Holmes C. Systemic infections and inflammation affect chronic neurodegeneration. Nat. Rev. Immunol. 7 (2007) 161-167
36. Perry V.H., Newman T.A., and Cunningham C. The impact of systemic infection on the progression of neurodegenerative disease. Nat. Rev. Neurosci. 4 (2003) 103-112
37. Pitossi F., del Rey A., Kabiersch A., and Besedovsky H. Induction of cytokine transcripts in the central nervous system and pituitary following peripheral administration of endotoxin to mice. J. Neurosci. Res. 48 (1997) 287-298
38. Platt N., Suzuki H., Kurihara Y., Kodama T., and Gordon S. Role for the class A macrophage scavenger receptor in the phagocytosis of apoptotic thymocytes in vitro. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 12456-12460
39. Savill J., Dransfield I., Gregory C., and Haslett C. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2 (2002) 965-975
40. Sievers C., Platt N., Perry V.H., Coleman M.P., and Conforti L. Neurites undergoing Wallerian degeneration show an apoptotic-like process with Annexin V positive staining and loss of mitochondrial membrane potential. Neurosci. Res. 46 (2003) 161-169
41. Smith K.J., Kapoor R., Hall S.M., and Davies M. Electrically active axons degenerate when exposed to nitric oxide. Ann. Neurol. 49 (2001) 470-476
42. Smith M.E., van der Maesen K., and Somera F.P. Macrophage and microglial responses to cytokines in vitro: phagocytic activity, proteolytic enzyme release, and free radical production. J. Neurosci. Res. 54 (1998) 68-78
43. Stoll G., Schroeter M., Jander S., Siebert H., Wollrath A., Kleinschnitz C., and Bruck W. Lesion-associated expression of transforming growth factor-beta-2 in the rat nervous system: evidence for down-regulating the phagocytic activity of microglia and macrophages. Brain Pathol. 14 (2004) 51-58
44. Suzuki S., Tanaka K., Nogawa S., Nagata E., Ito D., Dembo T., and Fukuuchi Y. Temporal profile and cellular localization of interleukin-6 protein after focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 19 (1999) 1256-1262
45. Turrin N.P., Gayle D., Ilyin S.E., Flynn M.C., Langhans W., Schwartz G.J., and Plata-Salaman C.R. Pro-inflammatory and anti-inflammatory cytokine mRNA induction in the periphery and brain following intraperitoneal administration of bacterial lipopolysaccharide. Brain Res. Bull. 54 (2001) 443-453
46. Vallieres N., Berard J.L., David S., and Lacroix S. Systemic injections of lipopolysaccharide accelerates myelin phagocytosis during Wallerian degeneration in the injured mouse spinal cord. Glia 53 (2006) 103-113
47. van Dam A.M., Brouns M., Louisse S., and Berkenbosch F. Appearance of interleukin-1 in macrophages and in ramified microglia in the brain of endotoxin-treated rats: a pathway for the induction of non-specific symptoms of sickness?. Brain Res. 588 (1992) 291-296
48. van der Laan L.J., Ruuls S.R., Weber K.S., Lodder I.J., Dopp E.A., and Dijkstra C.D. Macrophage phagocytosis of myelin in vitro determined by flow cytometry: phagocytosis is mediated by CR3 and induces production of tumor necrosis factor-alpha and nitric oxide. J. Neuroimmunol. 70 (1996) 145-152
49. Walsh D.T., Perry V.H., and Minghetti L. Cyclooxygenase-2 is highly expressed in microglial-like cells in a murine model of prion disease. Glia 29 (2000) 392-396